Videos
Video
Meet the Team: Dr. Brian Betts
How aggressive graft versus host disease prophylaxis, nuanced donor selection and other approaches have led to critical gains in survival and cure rate and facilitate a safe and earlier return home.
Video
Roswell Park Welcomes New Vice Chair of Clinical Affairs: Dr. Peter Maslak
Peter Maslak, MD, is an expert Hematologic Oncologist, joining Roswell Park as Vice Chair of Clinical Affairs, Director of Flow Cytometry in the Immune Monitoring Shared Resource and the Technical Director of the Flow Cytometry Lab.
Video
Roswell Park Researchers Present New Approach to Understanding Challenging CAR T-Cell Toxicities
Roswell Park Comprehensive Cancer Center pre-doctoral trainee Payal Goala, MS, BS, presented research findings that hold potential to help address two significant toxicities associated with Chimeric Antigen Receptor (CAR) T-cell therapy.
Video
CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan ...
Video
Physician-Scientist Marco Davila, MD, PhD, Joins Growing Roswell Park Cellular Therapy Program
Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
Video
Reaching Deep Remissions with a New Therapy for Multiple Myeloma Patients
Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.
News
News
Three physician-scientists who have relocated to Buffalo, New York, to join Roswell Park Comprehensive Cancer Center will apply highly specialized transplantation and cell therapy (TCT) expertise to both patient care and the development ...
News
Preventing GVHD and Improving Outcomes for Stem Cell Transplant
Several factors contribute to improving the success and safety of allogeneic stem cell transplant. At Roswell Park, we deploy three key strategies to help our patients achieve better outcomes and quality of life.
News
Roswell Park Cancer Innovation SurVaxM Granted FDA Fast Track Designation
A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA).
This site is intended for healthcare professionals
Download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED